From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
Automated gross-to-net accruals empowers pharmaceutical finance teams to make informed, educated business decisions, driving better visibility and product profitability.
Pharmaceutical finance and market access teams face four critical business challenges – inefficiency and rework, risky manual process, financial statement errors, audit points & compliance issues – as they try to accurately accrue for the vast number of rebates, discounts, chargebacks, admin fees, copay programs, and other sales-related adjustments and incentives.
IntegriChain’s Gross-to-net (GTN) software is an end-to-end revenue solution for your market access and finance departments. Offered as Software-as-a-Service (SaaS), Business Process-as-a-Service (BPaaS), and hybrid operating models, our deployment options are flexible, scalable, auditable, and customizable to your business needs. By automating GTN, you can improve margins, reduce costs, mitigate risk, and drive business decisions based on actionable analytics.
The functionality of GTN Accruals is configured for all standard line items with robust out-of-the-box accrual methodologies including:
IntegriChain’s GTN Accruals solution is part of our broader GTN solution that delivers on four distinct types of capabilities:
Automate Your GTN Processes
Whether manufacturers are entering new therapeutic categories, exploring new indications for a current product, or looking to acquire a new product through acquisition, portfolio growth presents both opportunities and challenges.
Read the Blog
In the current pharmaceutical landscape, more than 80% of manufacturers still rely on manual processes to accrue, forecast, and report their gross-to-net (GTN) deductions. However, in the era of big data and technological enhancements, manual processes cannot be relied on forever.
